Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, ChronicInterventions: Drug: Sitagliptin; Drug: Glipizide; Drug: Placebo for Sitagliptin; Drug: Placebo for GlipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Glipizide | Januvia | Research